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organisms ranging from yeast to mice,
indicating that generation of this gas
may play a conserved protective role in
many organisms, at least when gener-
ated at a specific concentration. In fact,
H2S has been traditionally regarded as
a toxic gas, but recent findings indicate
that it functions as a signaling molecule
with potential therapeutic applications in
a variety of conditions, including its
remarkable ability to induce suspended
animation in mice. Hine and colleagues
have identified specific dietary interven-
tions that result in the generation of pro-
tective levels of H2S but also provided
data that advance our understanding of
the anti-aging mechanisms induced by
CR/PR. The identification of drugs that
induce the generation of protective levels
of H2S while eliminating the risk of toxic
side effects could have important clinical
applications for the treatment of a variety
of acute conditions, such as ischemia/
reperfusion and other types of damage
associated with surgery. The chronicuse of drugs promoting H2S for health-
span extension could instead be much
more problematic, as it is difficult to
predict what the side effects caused by
long-term use could be. If the effects
described in model organisms are
conserved in humans, protein restriction
without malnutrition or the consumption
of plant-based proteins with low sulfur
amino acid content may represent a
safer strategy to induce H2S generation
and take advantage of its protective
effects.
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The nature, biological characteristics, and contribution to organ physiology of skeletal stem cells
are not completely determined. Chan et al. andWorthley et al. demonstrate that a stem cell for skel-
etal tissues, and a systemofmore restricted, downstreamprogenitors, can be identified inmice and
demonstrate its role in skeletal tissue maintenance and regeneration.The groundbreaking concept that bone,
cartilage, marrow adipocytes, and hema-
topoiesis-supporting stroma could origi-
nate from a common progenitor and
putative stem cell was surprising at the
time when it was formulated (Owen and
Friedenstein, 1988). The putative stem
cell, nonhematopoietic in nature, would
be found in the postnatal bone marrow
stroma, generate tissues previously
thought of as foreign to each other, andsupport the turnover of tissues and organs
that self-renew at a much slower rate
compared to other tissues associated
with stem cells (blood, epithelia). This
concept also connected bone and bone
marrow as parts of a single-organ system,
implying their functional interplay. For
many years, the evidence underpinning
the concept has been incomplete. While
multipotency of stromal progenitors has
been demonstrated by in vivo transplan-tation experiments, self-renewal, the
defining property of a stem cell, has not
been easily demonstrated until recently
in humans (Sacchetti et al., 2007) and
mice (Me´ndez-Ferrer et al., 2010). Mean-
while, a confusing and plethoric terminol-
ogy has been introduced into the litera-
ture, which diverted and confounded
the search for a skeletal stem cell and its
physiological significance (Bianco et al.,
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Two studies in this issue of Cell (Chan
et al., 2015; Worthley et al., 2015), using
a combination of rigorous single-cell ana-
lyses and lineage tracing technologies,
mark significant steps toward rectifying
the course of skeletal stem cell discovery
by making several important points,
within and beyond skeletal physiology.
First, a stemcell for skeletal tissues, and
a system of more restricted, downstream
progenitors can in fact be identified and
linked to defined phenotype(s) in the
mouse. The system is framed concep-
tually, and approached experimentally,
similar to the hematopoietic system.
Second, based on its assayable func-
tions and potential, the stem cell at the
top of the hierarchy is defined as a skeletal
stem cell (SSC). As noted earlier (Sac-
chetti et al., 2007) (Bianco et al., 2013),
this term clarifies, well beyond semantics,
that the range of tissues that the self-
renewing stromal progenitor (originally
referred to as an ‘‘osteogenic’’ or ‘‘stro-
mal’’ stem cell) (Owen and Friedenstein,
1988) can actually generate in vivo, over-
laps with the range of tissues that make
up the skeleton.
Third, these cells are spatially
restricted, local residents of the bone/
bone marrow organ. The systemic circu-
lation is not a sizable contributor to their
recruitment to locally deployed functions.
Fourth, a native skeletogenic potential
is inherent to the system of progenitor/
stem cells found in the skeleton, and
internally regulated by bone morphoge-
netic protein (BMP) signaling. This is
reflected in the expression of regu-
lators and antagonists of BMP signaling
within the system, highlighting poten-
tial feedback mechanisms modulating
expansion or quiescence of specific cell
compartments.
Fifth, in cells isolated from other tis-
sues, an assayable skeletogenic potential
is not inherent: it can only be induced de
novo by BMP reprogramming. These
two studies (Chan et al., 2015, Worthley
et al., 2015) corroborate the classical
concept of ‘‘determined’’ and ‘‘inducible’’
skeletal progenitors (Owen and Frieden-
stein, 1988): the former residing in the
skeleton, the latter found in nonskeletal
tissues; the former capable of generating
skeletal tissues, in vivo and spontane-
ously, the latter requiring reprogramming
signals in order to acquire a skeletogenic18 Cell 160, January 15, 2015 ª2015 Elseviercapacity; the former operating in physio-
logical bone formation, the latter in
unwanted, ectopic bone formation in dis-
eases such as fibrodysplasia ossificans
progressiva.
A major question revolving around the
concept of a SSC is how and to what
extent it would contribute to postnatal
physiology and adaptive changes in
bone and bone marrow. Chan et al.
show that SSCs (recruited locally, without
significant contribution from the systemic
circulation) can contribute to fracture
healing. Worthley et al. show that ablation
of SSCs can affect bonemass, which rep-
resents the endpoint of bone growth and a
measure of skeletal health and disease.
However, more studies are needed to
determine in a quantitative manner the
direct contribution of stem and progenitor
cells to postnatal bone formation, mainte-
nance of the skeleton, and also to fracture
healing. We also need a better under-
standing of the mechanisms underpin-
ning, at a tissue level, the recruitment
and contribution of SSCs to the key
microscopic events of lifelong bone
renewal, which is important for translation
of biological insight into medicine. Spe-
cies specificities in patterns of bone and
bone marrow remodeling, including the
rate of adipogenesis in adulthood and ag-
ing, encourage efforts toward the further
dissection of the system of skeletal pro-
genitors in humans.
Both classical (Owen and Friedenstein,
1988) and recent observations (Omatsu
et al., 2010; Zhou et al., 2014) support
the concept of a common (stromal) pro-
genitor for bone, cartilage, and marrow
adipocytes comprised in bone as an or-
gan. However, the lineage tracing studies
of Chan et al. and Worthley et al. showing
that stromal cells, osteoblasts, and
chondrocytes, but not adipocytes, are
clonally derived from SCCs, challenges
this concept at a glance. The osteo-
chondral-stromal clonogenic progenitors
highlighted by the two studies may not
coincide, in space and time, with those
assayed by other studies and identified
as perisinusoidal reticular cells (Sacchetti
et al., 2007). Models accommodating
spatially and temporally discrete cohorts
of skeletal progenitors (Mizoguchi et al.,
2014) need to be further explored. Indeed,
in developing and growing bones, simul-
taneous, de novo chondrogenesis andInc.osteogenesis in the absence of adipogen-
esis occurs at specific sites distinct from
bone marrow and at different develop-
mental times. Likewise, bone and stro-
mal cells, but hardly any adipocytes, are
formed in the primary spongiosa of
a growing long bone. Adipogenesis in
bone marrow is a postnatal event and
does not begin until specific times and
at specific sites in different bones. Bone
cells and adipocytes, but not chondro-
cytes, are generated in the marrow envi-
ronment of an adult, aging or diseased
bone, in a balanced fashion that implies
a functional relationship (Abdallah and
Kassem, 2012). Elucidating the relation-
ship between bone and bone marrow fat
will help tackling major clinically relevant
issues such as osteoporosis and aging.
This will also help to clarify the relation-
ships, potential overlap, and at times
apparent discrepancies, between several
marker-defined populations of putative
skeletal stem cells that have been pro-
posed in multiple recent studies.
To optimize our ability to obtain specific
skeletal tissues for medical application,
the study by Chan et al. offers a glimpse
of another facet of the biology of SSC
lineages and progenitors. Chan et al.
show that a homogeneous cell population
inherently committed to chondrogenesis
can alter its output to generate bone
if cotransplanted with multipotent pro-
genitors. Conversely, osteogenic cells
can be shifted to a chondrogenic fate by
blockade of vascular endothelial growth
factor receptor, consistent with the avas-
cular and hypoxic milieu of cartilage.
This has two important implications: (1)
commitment is flexible in the system; (2)
the choir is as important as the soloist
and can modulate the solo tune.
Reversibility and population behavior
thus emerge as two features that may be
characteristic, albeit not unique, of the
stromal system, resonating with concep-
tually comparable evidence in the human
system.
The two studies by Chan et al. and
Worthely et al. emphasize the relevance
not only of their new data, but also of
a proper concept of a skeletal stem cell
per se, for proper clinical use. Confusion
arising from improper conceptualization
of skeletal stem cells hasmarkedly limited
clinical development of skeletal stem cell
biology. New possibilities arise from these
studies for understanding and ultimately
treating skeletal disorders.REFERENCES
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